162 related articles for article (PubMed ID: 38401478)
1. Salivary gland carcinoma: Towards a more personalised approach.
Rached L; Saleh K; Casiraghi O; Even C
Cancer Treat Rev; 2024 Mar; 124():102697. PubMed ID: 38401478
[TBL] [Abstract][Full Text] [Related]
2. A molecular guide to systemic therapy in salivary gland carcinoma.
Weaver AN; Lakritz S; Mandair D; Ulanja MB; Bowles DW
Head Neck; 2023 May; 45(5):1315-1326. PubMed ID: 36859797
[TBL] [Abstract][Full Text] [Related]
3. [New developments in molecular diagnostics of carcinomas of the salivary glands: "translocation carcinomas"].
Skálová A; Šteiner P; Vaneček T
Cesk Patol; 2016; 52(3):139-45. PubMed ID: 27526014
[TBL] [Abstract][Full Text] [Related]
4. Current diagnosis and treatment of salivary gland-type tumors of the lung.
Horio Y; Kuroda H; Masago K; Matsushita H; Sasaki E; Fujiwara Y
Jpn J Clin Oncol; 2024 Mar; 54(3):229-247. PubMed ID: 38018262
[TBL] [Abstract][Full Text] [Related]
5. Salivary Gland Cancers.
Tchekmedyian V
Hematol Oncol Clin North Am; 2021 Oct; 35(5):973-990. PubMed ID: 34503735
[TBL] [Abstract][Full Text] [Related]
6. [Salivary gland cancer: new therapeutic approaches].
Herrera Gomez RG; Mederos N; Szturz P; Degrauwe N; Jankovic J; Cristina V
Rev Med Suisse; 2023 May; 19(827):958-963. PubMed ID: 37195109
[TBL] [Abstract][Full Text] [Related]
7. Expression and mutational status of treatment-relevant targets and key oncogenes in 123 malignant salivary gland tumours.
Cros J; Sbidian E; Hans S; Roussel H; Scotte F; Tartour E; Brasnu D; Laurent-Puig P; Bruneval P; Blons H; Badoual C
Ann Oncol; 2013 Oct; 24(10):2624-2629. PubMed ID: 23933559
[TBL] [Abstract][Full Text] [Related]
8. Systemic therapy for salivary gland malignancy: current status and future perspectives.
Imamura Y; Kiyota N; Tahara M; Hanai N; Asakage T; Matsuura K; Ota I; Saito Y; Sano D; Kodaira T; Motegi A; Yasuda K; Takahashi S; Yokota T; Okano S; Tanaka K; Onoe T; Ariizumi Y; Homma A
Jpn J Clin Oncol; 2022 Apr; 52(4):293-302. PubMed ID: 35134985
[TBL] [Abstract][Full Text] [Related]
9. Genomics in non-adenoid cystic group of salivary gland cancers: one or more druggable entities?
Cavalieri S; Platini F; Bergamini C; Resteghini C; Galbiati D; Bossi P; Perrone F; Tamborini E; Quattrone P; Licitra L; Locati LD; Alfieri S
Expert Opin Investig Drugs; 2019 May; 28(5):435-443. PubMed ID: 30897975
[TBL] [Abstract][Full Text] [Related]
10. Advances and challenges in precision medicine in salivary gland cancer.
Lassche G; van Boxtel W; Ligtenberg MJL; van Engen-van Grunsven ACH; van Herpen CML
Cancer Treat Rev; 2019 Nov; 80():101906. PubMed ID: 31644971
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and therapeutic implications of new molecular biomarkers in salivary gland cancers.
Stenman G; Persson F; Andersson MK
Oral Oncol; 2014 Aug; 50(8):683-90. PubMed ID: 24856188
[TBL] [Abstract][Full Text] [Related]
12. New approaches in salivary gland carcinoma.
Even C; Baste N; Classe M
Curr Opin Oncol; 2019 May; 31(3):169-174. PubMed ID: 30844885
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive genomic profiles of metastatic and relapsed salivary gland carcinomas are associated with tumor type and reveal new routes to targeted therapies.
Ross JS; Gay LM; Wang K; Vergilio JA; Suh J; Ramkissoon S; Somerset H; Johnson JM; Russell J; Ali S; Schrock AB; Fabrizio D; Frampton G; Miller V; Stephens PJ; Elvin JA; Bowles DW
Ann Oncol; 2017 Oct; 28(10):2539-2546. PubMed ID: 28961851
[TBL] [Abstract][Full Text] [Related]
14. Whole-Genome Sequencing of Common Salivary Gland Carcinomas: Subtype-Restricted and Shared Genetic Alterations.
Karpinets TV; Mitani Y; Liu B; Zhang J; Pytynia KB; Sellen LD; Karagiannis DT; Ferrarotto R; Futreal AP; El-Naggar AK
Clin Cancer Res; 2021 Jul; 27(14):3960-3969. PubMed ID: 34011559
[TBL] [Abstract][Full Text] [Related]
15. Targeted therapy for advanced salivary gland carcinoma based on molecular profiling: results from MyPathway, a phase IIa multiple basket study.
Kurzrock R; Bowles DW; Kang H; Meric-Bernstam F; Hainsworth J; Spigel DR; Bose R; Burris H; Sweeney CJ; Beattie MS; Blotner S; Schulze K; Cuchelkar V; Swanton C
Ann Oncol; 2020 Mar; 31(3):412-421. PubMed ID: 32067683
[TBL] [Abstract][Full Text] [Related]
16. The Role of Molecular Testing in the Differential Diagnosis of Salivary Gland Carcinomas.
Skálová A; Stenman G; Simpson RHW; Hellquist H; Slouka D; Svoboda T; Bishop JA; Hunt JL; Nibu KI; Rinaldo A; Vander Poorten V; Devaney KO; Steiner P; Ferlito A
Am J Surg Pathol; 2018 Feb; 42(2):e11-e27. PubMed ID: 29076877
[TBL] [Abstract][Full Text] [Related]
17. Proteogenomic Analysis of Salivary Adenoid Cystic Carcinomas Defines Molecular Subtypes and Identifies Therapeutic Targets.
Ferrarotto R; Mitani Y; McGrail DJ; Li K; Karpinets TV; Bell D; Frank SJ; Song X; Kupferman ME; Liu B; Lee JJ; Glisson BS; Zhang J; Aster JC; Lin SY; Futreal PA; Heymach JV; El-Naggar AK
Clin Cancer Res; 2021 Feb; 27(3):852-864. PubMed ID: 33172898
[TBL] [Abstract][Full Text] [Related]
18. Next-generation sequencing in salivary gland carcinoma: Targetable alterations lead to a therapeutic advantage-Multicenter experience.
Moore A; Bar Y; Maurice-Dror C; Ospovat I; Sarfaty M; Korzets Y; Goldvaser H; Gordon N; Billan S; Gutfeld O; Popovtzer A
Head Neck; 2020 Apr; 42(4):599-607. PubMed ID: 31762146
[TBL] [Abstract][Full Text] [Related]
19. Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs).
Locati LD; Perrone F; Losa M; Mela M; Casieri P; Orsenigo M; Cortelazzi B; Negri T; Tamborini E; Quattrone P; Bossi P; Rinaldi G; Bergamini C; Calderone RG; Liberatoscioli C; Licitra L
Oral Oncol; 2009 Nov; 45(11):986-90. PubMed ID: 19574086
[TBL] [Abstract][Full Text] [Related]
20. Salivary Gland Carcinoma: Novel Targets to Overcome Treatment Resistance in Advanced Disease.
Di Villeneuve L; Souza IL; Tolentino FDS; Ferrarotto R; Schvartsman G
Front Oncol; 2020; 10():580141. PubMed ID: 33194707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
